JB Chemicals & Pharmaceuticals Ltd.

₹1,790.6-0.09%Dec 16, 11:00 AM IST

JBCHEPHARM•Health Technology•Pharmaceuticals: Major

Current Price

₹1,790.6-0.09%

Dec 16, 11:00 AM IST

Market Cap₹28,198.29 Cr

Business Overview

J.B. Chemicals & Pharmaceuticals Limited operates through 3 main business divisions including Domestic Business, International Business, Contract Development and Manufacturing Organization (CDMO).

Business Hierarchy Structure for J.B. Chemicals & Pharmaceuticals Limited

J.B. Chemicals & Pharmaceuticals Limited
- Domestic Business
  - Therapeutic Segments
    - Chronic Therapies
      - Cardiology
        Heart Failure
        Hypertension
        Lipid Management
      - Nephrology
    - Gastroenterology
      - Pro-biotics
    - Respiratory
    - Gynaecology
    - Paediatrics
    - Ophthalmology
      - Anti-infectives
      - Antiglaucoma
      - NSAIDs
      - Tear substitute drugs
    - Wound Care
    - Dental
    - Cough & Cold
  - Key Brands
    - Top 5 Iconic Brands (among top 150 IPM)
      - Nicardia
      - Cilacar
      - Rantac
      - Metrogyl
      - Cilacar-T
    - Cardiology Segment Brands (among top 20)
      - Cilacar
      - Nicardia
      - Cilacar-T
    - Top 10 Most Prescribed Brands
      - Rantac
      - Metrogyl
  - Manufacturing & Dosage Forms
    - State-of-the-art multi-dosage formulation plants
    - Dosage Forms
      - Tablets
      - Capsules
      - Liquids
      - Gels
      - Lozenges
      - Creams
      - Injectables
      - Powder
      - Cold Rubs
      - Eye Drops
      - Troches
  - Technology
    - OROS (Osmotic-controlled release oral drug delivery system) technology
    - Lozenges (drug delivery format)
- International Business
  - Geographical Presence
    - Direct Presence: Russia
    - Direct Presence: South Africa
    - Distributor Relationships: USA
    - Distributor Relationships: Mexico
    - Distributor Relationships: Latin America
    - Distributor Relationships: Canada
    - Distributor Relationships: Europe
    - Distributor Relationships: Algeria
    - Distributor Relationships: Middle East (Qatar, Oman, Jordan)
    - Distributor Relationships: Africa (Ethiopia, Sudan, Kenya, Uganda, Tanzania, Nigeria, Ivory Coast)
    - Distributor Relationships: South East Asia (Malaysia, Vietnam, Cambodia, Thailand, Myanmar, Philippines, Singapore, Hong Kong, Sri Lanka)
    - Distributor Relationships: Australia
    - Distributor Relationships: CIS (Uzbekistan, Kazakhstan, Belarus, Tajikistan, Azerbaijan, Moldova, Armenia)
    - Distributor Relationships: India
  - Product Categories
    - Branded Generics (Exports to Africa, South-east Asia, Gulf, Middle East, Central and South America)
    - Generics (Exports to USA, UK, South Africa, Australia, Canada)
    - Medicated Lozenges
    - Herbal Lozenges
    - Active Pharmaceutical Ingredients (API)
    - Tablets
    - Capsules
    - Herbal Syrups
    - Injectables
- Contract Development and Manufacturing Organization (CDMO)
  - Services: Contract Development and Manufacturing
  - Product Focus: Lozenges
    - Medicated Lozenges
    - Herbal Lozenges
  - Lozenges Portfolio Expansion
    - Sleep Disorder
    - Pain Management
    - Immunity Boosters
    - Anti-inflammatory Products